Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 72

1.
2.

Assessment of a sixteen-week training program on strength, pain, and function in rheumatoid arthritis patients.

Flint-Wagner HG, Lisse J, Lohman TG, Going SB, Guido T, Cussler E, Gates D, Yocum DE.

J Clin Rheumatol. 2009 Jun;15(4):165-71. doi: 10.1097/RHU.0b013e318190f95f.

PMID:
19279507
3.

SLE in a United States-Mexico border community.

Walsh BT, Pope C, Reid M, Gall EP, Yocum DE, Clark LC.

J Clin Rheumatol. 2001 Feb;7(1):3-9.

PMID:
17039079
4.

Response: office-based low-field extremity magnetic resonance imaging: is the glass half empty or half full?

Yocum DE, Conaghan PG, Olech E, Peterfy CG.

Arthritis Rheum. 2006 Apr;54(4):1048-50. No abstract available.

5.

Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis.

Clegg DO, Reda DJ, Harris CL, Klein MA, O'Dell JR, Hooper MM, Bradley JD, Bingham CO 3rd, Weisman MH, Jackson CG, Lane NE, Cush JJ, Moreland LW, Schumacher HR Jr, Oddis CV, Wolfe F, Molitor JA, Yocum DE, Schnitzer TJ, Furst DE, Sawitzke AD, Shi H, Brandt KD, Moskowitz RW, Williams HJ.

N Engl J Med. 2006 Feb 23;354(8):795-808.

6.

Severity of joint pain and Kellgren-Lawrence grade at baseline are better predictors of joint space narrowing than bone scintigraphy in obese women with knee osteoarthritis.

Mazzuca SA, Brandt KD, Schauwecker DS, Katz BP, Meyer JM, Lane KA, Bradley JD, Hugenberg ST, Wolfe F, Moreland LW, Heck LW, Yocum DE, Schnitzer TJ, Sharma L, Manzi S, Oddis CV.

J Rheumatol. 2005 Aug;32(8):1540-6.

PMID:
16078332
7.

Effects of doxycycline on progression of osteoarthritis: results of a randomized, placebo-controlled, double-blind trial.

Brandt KD, Mazzuca SA, Katz BP, Lane KA, Buckwalter KA, Yocum DE, Wolfe F, Schnitzer TJ, Moreland LW, Manzi S, Bradley JD, Sharma L, Oddis CV, Hugenberg ST, Heck LW.

Arthritis Rheum. 2005 Jul;52(7):2015-25.

8.

The benefit/risk profile of TNF-blocking agents: findings of a consensus panel.

Hochberg MC, Lebwohl MG, Plevy SE, Hobbs KF, Yocum DE.

Semin Arthritis Rheum. 2005 Jun;34(6):819-36. Review.

PMID:
15942917
9.

Subject retention and adherence in a randomized placebo-controlled trial of a disease-modifying osteoarthritis drug.

Mazzuca SA, Brandt KD, Katz BP, Lane KA, Bradley JD, Heck LW, Hugenberg ST, Manzi S, Moreland LW, Oddis CV, Schnitzer TJ, Sharma L, Wolfe F, Yocum DE.

Arthritis Rheum. 2004 Dec 15;51(6):933-40.

10.

Effects of prasterone on disease activity and symptoms in women with active systemic lupus erythematosus.

Petri MA, Mease PJ, Merrill JT, Lahita RG, Iannini MJ, Yocum DE, Ginzler EM, Katz RS, Gluck OS, Genovese MC, Van Vollenhoven R, Kalunian KC, Manzi S, Greenwald MW, Buyon JP, Olsen NJ, Schiff MH, Kavanaugh AF, Caldwell JR, Ramsey-Goldman R, St Clair EW, Goldman AL, Egan RM, Polisson RP, Moder KG, Rothfield NF, Spencer RT, Hobbs K, Fessler BJ, Calabrese LH, Moreland LW, Cohen SB, Quarles BJ, Strand V, Gurwith M, Schwartz KE.

Arthritis Rheum. 2004 Sep;50(9):2858-68.

11.

Increased activation-induced cell death in peripheral lymphocytes of rheumatoid arthritis patients: the mechanism of action.

Tang X, Yocum DE, Dejonghe D, Nordensson K, Lake DF, Richard J.

Immunology. 2004 Jul;112(3):496-505.

12.

Increased risk of coccidioidomycosis in patients treated with tumor necrosis factor alpha antagonists.

Bergstrom L, Yocum DE, Ampel NM, Villanueva I, Lisse J, Gluck O, Tesser J, Posever J, Miller M, Araujo J, Kageyama DM, Berry M, Karl L, Yung CM.

Arthritis Rheum. 2004 Jun;50(6):1959-66.

13.

Safety of tacrolimus in patients with rheumatoid arthritis: long-term experience.

Yocum DE, Furst DE, Bensen WG, Burch FX, Borton MA, Mengle-Gaw LJ, Schwartz BD, Wisememandle W, Mekki QA; Tacrolimus RA Study Group.

Rheumatology (Oxford). 2004 Aug;43(8):992-9. Epub 2004 Mar 10.

PMID:
15014199
14.

Efficacy and safety of tacrolimus in patients with rheumatoid arthritis: a double-blind trial.

Yocum DE, Furst DE, Kaine JL, Baldassare AR, Stevenson JT, Borton MA, Mengle-Gaw LJ, Schwartz BD, Wisemandle W, Mekki QA; Tcrolimus Rheumatoid Arthritis Study Group.

Arthritis Rheum. 2003 Dec;48(12):3328-37.

15.

The role of T-cells in rheumatoid arthritis and the use of immunomodulating drugs.

Yocum DE.

Drugs Today (Barc). 1999 Apr-May;35(4-5):295-307.

PMID:
12973434
16.

Natural autoantibodies to TCR public idiotopes: potential roles in immunomodulation.

Schluter SF, Adelman MK, Taneja V, David C, Yocum DE, Marchalonis JJ.

Cell Mol Biol (Noisy-le-grand). 2003 Mar;49(2):193-207.

PMID:
12887102
17.

Characterizing a soluble survival signal for activated lymphocytes from CD14+ cells.

Tang X, Yocum DE, DeJonghe D, Nordensson K.

Immunology. 2002 Sep;107(1):56-68.

18.

Human monoclonal natural autoantibodies against the T-cell receptor inhibit interleukin-2 production in murine T cells.

Robey IF, Schluter SF, Akporiaye E, Yocum DE, Marchalonis JJ.

Immunology. 2002 Apr;105(4):419-29.

19.

Specificity mapping of human anti-T cell receptor monoclonal natural antibodies: defining the properties of epitope recognition promiscuity.

Robey IF, Edmundson AB, Schluter SF, Yocum DE, Marchalonis JJ.

FASEB J. 2002 May;16(7):642-52.

PMID:
11978728
20.

Combination therapy: the risks of infection and tumor induction.

Yocum DE.

Springer Semin Immunopathol. 2001;23(1-2):63-72. Review.

PMID:
11455862
21.

Treatment of rheumatoid arthritis with a DR4/1 peptide.

St Clair EW, Cohen SB, Lee ML, Fleischmann RM, Lee SH, Moreland LW, Olsen NJ, Pratt PW, Yocum DE, Heck L, Winkelhake J, Holcenberg JS, Shulman MJ.

J Rheumatol. 2000 Aug;27(8):1855-63.

PMID:
10955324
22.

Production and characterization of monoclonal IgM autoantibodies specific for the T-cell receptor.

Robey IF, Schluter SF, Yocum DE, Marchalonis JJ.

J Protein Chem. 2000 Jan;19(1):9-21.

PMID:
10882168
23.

Epitope promiscuity of human monoclonal autoantibodies to T-cell receptor-combining site determinants.

Marchalonis JJ, Robey I, Schluter SF, Yocum DE.

Appl Biochem Biotechnol. 2000 Jan-Mar;83(1-3):31-49; discussion 49-52, 145-53.

PMID:
10826947
24.

Microemulsion formulation of cyclosporin (Sandimmun Neoral) vs Sandimmun: comparative safety, tolerability and efficacy in severe active rheumatoid arthritis. On behalf of the OLR 302 Study Group.

Yocum DE, Allard S, Cohen SB, Emery P, Flipo RM, Goobar J, Jayawardena S, Job-Deslandre C, Jubb RW, Kr├╝ger K, Lopes Vaz A, Manger B, Mur E, Nygaard H, Weiner SM, Rainer F, Sack MR, Schiff MH, Schnitzer TJ, Trigg LB, Whatmough I, Schmidt AG.

Rheumatology (Oxford). 2000 Feb;39(2):156-64.

PMID:
10725065
25.

Exercise, education, and behavioral modification as alternative therapy for pain and stress in rheumatic disease.

Yocum DE, Castro WL, Cornett M.

Rheum Dis Clin North Am. 2000 Feb;26(1):145-59, x-xi. Review.

PMID:
10680202
26.

T cells: pathogenic cells and therapeutic targets in rheumatoid arthritis.

Yocum DE.

Semin Arthritis Rheum. 1999 Aug;29(1):27-35. Review.

PMID:
10468412
27.

Glucocorticosteroids in rheumatoid arthritis: lessons for the future.

Yocum DE.

Br J Rheumatol. 1998 Nov;37(11):1145-7. No abstract available.

PMID:
9851258
28.

Arthritis and HLA-B27 in native North American tribes.

Walsh B, Yocum DE, Khan MA.

Curr Opin Rheumatol. 1998 Jul;10(4):319-25. Review.

PMID:
9725093
29.

The many faces of carpal tunnel syndrome.

Yocum DE.

Arch Intern Med. 1998 Jul 27;158(14):1496. No abstract available.

PMID:
9679789
30.

Clinical and immunologic effects of a PRIMATIZED anti-CD4 monoclonal antibody in active rheumatoid arthritis: results of a phase I, single dose, dose escalating trial.

Yocum DE, Solinger AM, Tesser J, Gluck O, Cornett M, O'Sullivan F, Nordensson K, Dallaire B, Shen CD, Lipani J.

J Rheumatol. 1998 Jul;25(7):1257-62.

PMID:
9676753
32.

Subcutaneous administration of CAMPATH-1H: clinical and biological outcomes.

Schnitzer TJ, Yocum DE, Michalska M, Balius R, Snider ME, Hays A, Thurmond LM, Johnston JM.

J Rheumatol. 1997 Jun;24(6):1031-6.

PMID:
9195505
33.

Fine specificity analysis of autoantibodies to T cell receptor CDR1 segments in rheumatoid arthritis.

Landsperger WJ, Schluter SF, Garza A, Yocum DE, Marchalonis JJ.

Ann N Y Acad Sci. 1997 Apr 5;815:459-61. No abstract available.

PMID:
9186696
34.

Combination therapy with cyclosporin in rheumatoid arthritis.

Yocum DE.

Br J Rheumatol. 1996 Sep;35 Suppl 2:19-23. Review.

PMID:
8810686
35.

Combination therapy with cyclosporine in rheumatoid arthritis.

Yocum DE.

J Rheumatol Suppl. 1996 Mar;44:75-7. Review.

PMID:
8833059
36.

Cyclosporine, FK-506, rapamycin, and other immunomodulators.

Yocum DE.

Rheum Dis Clin North Am. 1996 Feb;22(1):133-54. Review.

PMID:
8907069
37.

Proceedings of the Psoriasis Combination and Rotation Therapy Conference. Deer Valley, Utah, Oct. 7-9, 1994.

Menter MA, See JA, Amend WJ, Ellis CN, Krueger GG, Lebwohl M, Morison WL, Prystowsky JH, Roenigk HH Jr, Shupack JL, Silverman AK, Weinstein GD, Yocum DE, Zanolli MD.

J Am Acad Dermatol. 1996 Feb;34(2 Pt 1):315-21. No abstract available. Erratum in: J Am Acad Dermatol 1996 Jun;34(6):1029.

PMID:
8642106
38.

An in vitro Model for Studying Mechanisms Underlying Synoviocyte-Mediated Cartilage Invasion in Rheumatoid Arthritis.

Frye CA, Yocum DE, Tuan R, Suyana E, Seftor EA, Seftor RE, Khalkhali-Ellis Z, Moore TL, Hendrix MJ.

Pathol Oncol Res. 1996;2(3):157-166.

39.

Treatment of active refractory rheumatoid arthritis with humanized monoclonal antibody CAMPATH-1H administered by daily subcutaneous injection.

Matteson EL, Yocum DE, St Clair EW, Achkar AA, Thakor MS, Jacobs MR, Hays AE, Heitman CK, Johnston JM.

Arthritis Rheum. 1995 Sep;38(9):1187-93.

PMID:
7575711
40.

Cyclosporine in rheumatoid arthritis.

Yocum DE, Torley H.

Rheum Dis Clin North Am. 1995 Aug;21(3):835-44. Review.

PMID:
8619102
41.

Combination therapy with cyclosporin in rheumatoid arthritis.

Yocum DE.

Drugs. 1995;50 Suppl 1:37-40. Review.

PMID:
8714797
42.

Autoregulation of Tcr V region epitopes in autoimmune disease.

Schluter SF, Wang E, Winfield JB, Yocum DE, Marchalonis JJ.

Adv Exp Med Biol. 1995;383:231-6.

PMID:
8644507
43.

Synthetic autoantigens of immunoglobulins and T-cell receptors: their recognition in aging, infection, and autoimmunity.

Marchalonis JJ, Schluter SF, Wang E, Dehghanpisheh K, Lake D, Yocum DE, Edmundson AB, Winfield JB.

Proc Soc Exp Biol Med. 1994 Nov;207(2):129-47. Review.

PMID:
7938045
44.

The use of immunomodulators in early rheumatoid arthritis.

Yocum DE.

Semin Arthritis Rheum. 1994 Jun;23(6 Suppl 2):44-9. Review.

PMID:
7939731
45.

Naturally occurring human autoantibodies to defined T-cell receptor and light chain peptides.

Marchalonis JJ, Kaymaz H, Schluter SF, Yocum DE.

Adv Exp Med Biol. 1994;347:135-45.

PMID:
7976728
46.

Natural human antibodies to synthetic peptide autoantigens: correlations with age and autoimmune disease.

Marchalonis JJ, Schluter SF, Wilson L, Yocum DE, Boyer JT, Kay MM.

Gerontology. 1993;39(2):65-79.

PMID:
8514202
47.

Human autoantibodies to a synthetic putative T cell receptor beta-chain regulatory idiotype: expression in autoimmunity and aging.

Marchalonis JJ, Kaymaz H, Schluter SF, Yocum DE.

Exp Clin Immunogenet. 1993;10(1):1-15.

PMID:
8398197
48.

Lack of preferential V beta usage in synovial T cells of rheumatoid arthritis patients.

Dedeoglu F, Kaymaz H, Seaver N, Schluter SF, Yocum DE, Marchalonis JJ.

Immunol Res. 1993;12(1):12-20.

PMID:
8390552
49.

Uptake and intracellular survival of Bordetella pertussis in human macrophages.

Friedman RL, Nordensson K, Wilson L, Akporiaye ET, Yocum DE.

Infect Immun. 1992 Nov;60(11):4578-85.

50.

Cyclosporine in rheumatoid arthritis: beyond experimentation.

Yocum DE.

Semin Arthritis Rheum. 1992 Jun;21(6 Suppl 3):39-42. Review.

PMID:
1502566

Supplemental Content

Loading ...
Support Center